Stockreport

bioAffinity Technologies Reports Third Quarter 2025 Financial Results

bioAffinity Technologies, Inc.  (BIAF) 
PDF Company achieves 86% increase in CyPath® Lung testing revenue, strengthens balance sheet SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; B [Read more]